[1] |
W helton P K, C arey R M, A ronow W S, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APHA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines[J]. Hypertension, 2018,71(6):1269-1324.
doi: 10.1161/HYP.0000000000000066
pmid: 29133354
|
[2] |
L ewington S, C larke R, Q izilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies[J]. Lancet, 2002,361:1903-1913.
|
[3] |
R apsomaniki E, T immis A, G eorge J, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people[J]. Lancet, 2014,383:1899-1911.
doi: 10.1016/S0140-6736(14)60685-1
pmid: 24881994
|
[4] |
W illiamson J D, S upiano M A, A pplegate W B, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged $>$=75 years a randomized clinical trial[J]. Journal of the American Medical Association, 2016,315(24):2673-2682.
doi: 10.1001/jama.2016.7050
pmid: 27195814
|
[5] |
M untner P, C arey R M, G idding S, et al. Potential US population impact of the 2017 ACC/AHA high blood pressure guideline[J]. Journal of the American College of Cardiology, 2018,71(2):109-118.
doi: 10.1016/j.jacc.2017.10.073
pmid: 29146532
|
[6] |
B angalore S, T oklu B, G ianos E, et al. Optimal systolic blood pressure target after SPRINT: insights from a network meta-analysis of randomized trials[J]. American Journal of Medicine, 2017,130(6):707-719.
pmid: 28109971
|
[7] |
D enardo S J, G ong Y, N ichols W W, et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy[J]. American Journal of Medicine, 2010,123(8):719-726.
pmid: 20670726
|
[8] |
C ushman W C, E vans G W, B yington R P, et al. Effects of intensive blood-pressure control in Type 2 diabetes mellitus[J]. New England Journal of Medicine, 2010,362(17):1575-1585.
doi: 10.1056/NEJMoa1001286
pmid: 20228401
|
[9] |
Z anchetti A, H ansson L, C lement D, et al. Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?[J]. Journal of Hypertension, 2003,21(4):797-804.
doi: 10.1097/00004872-200304000-00024
pmid: 12658027
|
[10] |
L onn E M, B osch J, L opez-J aramillo P, et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease[J]. New England Journal of Medicine, 2016,374(21):2009-2020.
doi: 10.1056/NEJMoa1600175
pmid: 27041480
|
[11] |
L u J P, L u Y, W ang X C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE million persons project)[J]. Lancet, 2017,390:2549-2558.
pmid: 29102084
|
[12] |
W ang X B, Q in X H, D emirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis[J]. Lancet, 2007,369:1876-1882.
doi: 10.1016/S0140-6736(07)60854-X
pmid: 17544768
|